Audiovisual Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment (ADELANTE) Study in Radiation Oncology
The study aims to develop educational media interventions to prepare Latinx Spanish-speaking radiation oncology patients for a course of breast or prostate cancer radiation therapy and to foster receptivity and informed decision-making around cancer clinical trial participation.
• Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry
• Currently undergoing treatment for breast or prostate cancer, or recently been treated
• Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry
• Patients with non-metastatic prostate or breast cancer
• Histopathologically proven diagnosis of prostate or breast cancer
• History and physical examination within 28 days prior to enrollment
• Karnofsky performance status 70 or greater
• For women of childbearing potential, pregnancy testing to be performed in accordance to institutional guidelines
• Plan to receive definitive, curative radiation. Patients planning to receive curative RT after upcoming adjuvant chemotherapy or induction hormonal therapy may enroll at reconsult follow-up visit.
• Consultation visit must be performed with a certified interpreter